Healthcare >> CEO Interviews >> February 19, 2001
DR. JOHN CHIPLIN President, Chief Executive Officer and co-founder of
GeneFormatics, Inc. has worked for a number of early'stage bio-infotech
companies that went on to become successful, multinational, profitable
companies including Molecular Design Limited and Biosym Technologies,
Inc. Immediately prior to co-founding GeneFormatics, Dr. Chiplin was
Chief Executive Officer of Superscape Plc, one of the world's leading
virtual reality technology companies, quoted on the London Stock
Exchange. Born in 1958, he holds a BS in Pharmacy and a PhD in
Biochemistry from the University of Nottingham, England. Professional
affiliations include memberships in the Pharmaceutical Society, the
Royal Society of Arts, and the Institute of Directors. Profile
of GeneFormatics?
Dr. Chiplin: GeneFormatics is a company that we started in December of
1998. It is based on the
